No retraction, correction or concern found when last checked on Oct 31, 2026.
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
David J. Ahern, Zhichao Ai, Mark Ainsworth and 97 more
Cell · 2022
doi:10.1016/j.cell.2022.01.012
Abstract
Treatment of severe COVID-19 is currently limited by clinical heterogeneity and incomplete description of specific immune biomarkers. We present here a comprehensive multi-omic blood atlas for patients with varying COVID-19 severity in an integrated comparison with influenza and sepsis patients versus healthy volunteers. We identify immune signatures and correlates of host response. Hallmarks of disease severity involved cells, their inflammatory mediators and networks, including progenitor cells and specific myeloid and lymphocyte subsets, features of the immune repertoire, acute phase response, metabolism, and coagulation. Persisting immune activation involving AP-1/p38MAPK was a specific feature of COVID-19. The plasma proteome enabled sub-phenotyping into patient clusters, predictive of severity and outcome. Systems-based integrative analyses including tensor and matrix decomposition of all modalities revealed feature groupings linked with severity and specificity compared to influenza and sepsis. Our approach and blood atlas will support future drug development, clinical trial design, and personalized medicine approaches for COVID-19.
Cited by papers we hold 6
- Immune system adaptation during gender-affirming testosterone treatment · 2024Corrected
- Human SARS-CoV-2 challenge uncovers local and systemic response dynamics · 2024Corrected
- Applications of multi‐omics analysis in human diseases · 2023No notice
- Population-level integration of single-cell datasets enables multi-scale analysis across samples · 2023No notice
- Secondary influenza challenge triggers resident memory B cell migration and rapid relocation to boost antibody secretion at infected sites · 2022No notice
- An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease · 2021No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.